title: Low-dose methotrexate as treatment of myeloproliferative neoplasms: Proof of principle of clinical activity.
authors.affiliation: Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and a. Seràgnoli," University of Bologna, Bologna, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Palandri
authors.affiliation: Division of Hematology, Azienda Ospedaliera "Bianchi Melacrino Morelli, "Reggio Calabria, Italy.
authors.forename: Claudia
authors.initials: C
authors.lastname: Labate
authors.affiliation: Hematopathology Unit, Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
authors.forename: Elena
authors.initials: E
authors.lastname: Sabattini
authors.affiliation: Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and a. Seràgnoli," University of Bologna, Bologna, Italy.
authors.forename: Lucia
authors.initials: L
authors.lastname: Catani
authors.affiliation: Division of Hematology, Azienda Ospedaliera "Bianchi Melacrino Morelli, "Reggio Calabria, Italy.
authors.forename: Bruno
authors.initials: B
authors.lastname: Martino
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate